Know what’s really happening at
Pelage Pharmaceuticals before you sign on.
- On the roadmap
- Regenerative Medicine
- HealthTech
- Hair Loss Treatment
Pelage Pharmaceuticals is a clinical-stage biotech developing a non-invasive topical treatment that reactivates dormant hair follicle stem cells to restore natural hair growth. With top-tier investors and a Phase 2a candidate targeting androgenetic alopecia, the company is pursuing a large underserved market with a novel non-hormonal approach.
How we do it.
Most "AI market intel" is a summarized crawl of press releases. This Altis research is built from our knowledge graph of sector expert calls, synthesized with public sources.
Pelage Pharmaceuticals
- Total Funding
- ~$151M
- Last Funding Round Type
- Series B
- Last Round Size
- ~$120M
- Year Founded
- 2018
- Employee Count
- 14
- Headquarters
- Los Angeles, California, United States
- Lead Investor
- Google Ventures
- Lead Investor
- ARCH Venture Partners
Press reported
Altis Verified
What's in the report
Most "AI market intel" is a summarized crawl of press releases. This is what customers, competitors, and former employees actually told us.
Market Overview
Market structure, where the company sits, and growth drivers.
- market map
- Regenerative Medicine landscape
- Regenerative Medicine growth rate
- CAGR
Total Addressable Market
Bottom-up TAM / SAM / SOM.
- Pelage Pharmaceuticals TAM
- Regenerative Medicine market size
- market opportunity
Company Overview
What the company does and how it operates.
- what does Pelage Pharmaceuticals do
- Pelage Pharmaceuticals product
- business model
Product / Go-to-Market
Product, GTM motion, ICP, and who buys.
- Pelage Pharmaceuticals customers
- who uses Pelage Pharmaceuticals
- Pelage Pharmaceuticals ICP
- go-to-market
Competitive Dynamics
The Altis Market Map and the Altis Win-Rate Index.
- Pelage Pharmaceuticals competitors
- Pelage Pharmaceuticals alternatives
- who competes with Pelage Pharmaceuticals
- Pelage Pharmaceuticals win rate
Customer Signals
Retention, satisfaction, and win/loss signals.
- Pelage Pharmaceuticals reviews
- Pelage Pharmaceuticals NRR
- Pelage Pharmaceuticals churn
- current customers
- switching costs
Investment Debates
Investment thesis, moat, bull/bear, and key risks.
- Pelage Pharmaceuticals investment thesis
- Pelage Pharmaceuticals moat
- bull case bear case
- Pelage Pharmaceuticals risk factors
Monetization & Financials
Business model, revenue model, and unit economics.
- Pelage Pharmaceuticals ARR
- Pelage Pharmaceuticals revenue
- Pelage Pharmaceuticals valuation
- unit economics
Team and culture
Founders, leadership, and org.
- Pelage Pharmaceuticals founders
- Pelage Pharmaceuticals CEO background
- leadership team
- headcount
Trusted by
Ready to see the full picture?
Profile based on Altis structured company data and growth signal tracking as of July 2026.